TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 8 | 76 | 31 | 87 | 58 | -1 | 43 |
| P | %wins | 100 | 100 | 50 | 100 | 100 | 0 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/21/16 18:43 | 10/19/16 | BIOC | Biocept Inc | DE | Health | Health | Medical Laboratories | Nall Michael W. | CA | DO | CEO,P | P.d | 40 | 1.10 | 0 | 36 | 95 | 75 | M | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | |
8/25/15 17:35 | 8/24/15 | BIOC | Biocept Inc | DE | Health | Health | Medical Laboratories | Nall Michael W. | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 14 | 119 | 26 | D | -55 | -42 | -32 | -30 | -17 | 12 | -9 | -4 | 5 | 33 | 0 | -39 | -64 | |
2/18/15 14:03 | 2/13/15 | BIOC | Biocept Inc | DE | Health | Health | Medical Laboratories | Nall Michael W. | CA | DO | CEO,P | P.d | 15 | 1.25 | 0 | 12 | New | 12 | D | -85 | -70 | -60 | -44 | -39 | -21 | 16 | 10 | 144 | 65 | 116 | 34 | -1 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |